MicroRNA‑608 sensitizes non‑small cell lung cancer cells to cisplatin by targeting TEAD2
Authors:
Open Access
- 26 August 2019
- journal article
- research article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 20 (4) , 3519-3526
Abstract
Cisplatin has been widely used as a conventional treatment for patients with non‑small cell lung cancer (NSCLC). However, primary and acquired cisplatin resistances are frequently developed during the treatment of patients with NSCLC, leading to an increased mortality rate. Accumulating evidence demonstrated that aberrantly expressed microRNAs (miRs) are involved in the development of chemoresistance. In the present study, sensitivity of NSCLC cells to cisplatin was identified to increase following overexpression of miR‑608. Conversely, sensitivity to cisplatin was reduced following miR‑608 knockdown. Reverse transcription‑quantitative PCR and western blotting analyses identified that TEA domain transcription factor 2 (TEAD2), a key regulator of cell stemness, was negatively regulated by miR‑608 in NSCLC cells. By repressing TEAD2, miR‑608 decreased the expression level of several target genes of the Hippo‑yes‑associated protein signaling pathway. Furthermore, TEAD2 mRNA was confirmed to be targeted by miR‑608 in NSCLC cells via a dual‑luciferase reporter assay. Importantly, the increased cisplatin sensitivity induced by miR‑608 overexpression was reversed by transfection of TEAD2 in NSCLC cells. The present data suggested that miR‑608 may represent a novel candidate biomarker for the evaluation of cisplatin sensitivity in patients with NSCLC.Keywords
This publication has 41 references indexed in Scilit:
- Annual number of lung cancer deaths potentially avertable by screening in the United StatesCancer, 2013
- The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domainProceedings of the National Academy of Sciences, 2012
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive reviewEMBO Molecular Medicine, 2012
- Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549)Journal of Experimental & Clinical Cancer Research, 2011
- The widespread regulation of microRNA biogenesis, function and decayNature Reviews Genetics, 2010
- Structural and functional analysis of the YAP-binding domain of human TEAD2Proceedings of the National Academy of Sciences, 2010
- MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor propertiesBiochemical and Biophysical Research Communications, 2010
- TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal TransitionJournal of Biological Chemistry, 2009
- Redundant Roles of Tead1 and Tead2 in Notochord Development and the Regulation of Cell Proliferation and SurvivalMolecular and Cellular Biology, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001